MR Assessment of Myocardial Viability

Similar documents
Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes

J. Schwitter, MD, FESC Section of Cardiology

Perfusion, Viability, Edema and Hemorrhage: How it Can (and Should) Change Clinical Practice. Rohan Dharmakumar, Ph.D.

The role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.

Myocardial viability testing. What we knew and what is new

Cardial MRI; Approaching the Level of Gold Standard for Viability Assessment

Imaging in Ischemic Heart Disease: Role of Cardiac MRI

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Case based learning: CMR in Heart Failure

Rational use of imaging for viability evaluation

Radiologic Assessment of Myocardial Viability

The use of Cardiac CT and MRI in Clinical Practice

Gated blood pool ventriculography: Is there still a role in myocardial viability?

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

3/27/2014. Introduction.

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Assessment of Ischemia and Viability

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

MRI ACS-ben. Tamás Simor MD, PhD, Med Hab. University of Pécs, Heart Institute

Acute Myocardial Infarction

Imaging of Coronary Artery Disease: II

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Echo is Still Strong in Myocardial Viability Wook-Jin Chung, MD, PhD

Old and new insights into viability:perfusion and Perfusion Reserve

Assessment Of Myocardial Viability

CASE from South Korea

Qualitative and Quantitative Assessment of Perfusion

Stable Angina: Indication for revascularization and best medical therapy

Coronary interventions

Cardiac MRI: Cardiomyopathy

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Advanced Imaging MRI and CTA

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Coronary Revascularization in Patients witj Severe LV Dysfunction.: Is the concept of viability still viable?

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Newly Diagnosed Heart Failure patient: When to Order an MRI and Why

Echo in CAD: Wall Motion Assessment

Current Indications for Cardiac MRI: What You See is What You Get?

Invited Experts' Case Presentation and 5-Slides Focus Review

Cardiac Stress MRI: Detection of Ischemia. Disclosures: Dobutamine Stress MR. April 28, 2018

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Original Research. Li-Yueh Hsu, DSc, W. Patricia Ingkanisorn, MD, Peter Kellman, PhD, Anthony H. Aletras, PhD, and Andrew E.

Magnetic Resonance Imaging for the Assessment of Myocardial Viability

Imaging and heart failure

Assessment of myocardial viability by cardiovascular magnetic resonance imaging

Coronary Revascularization for Severe LV Dysfunction Is s. Is the concept of viability testing still viable?

M/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl #

CT for Myocardial Characterization of Cardiomyopathy. Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea

Imaging Saves Lives: An Evidence-Based Choice of Modality Magnetic Resonance Imaging

presenters 2010 Sameh Sabet Ain Shams University

Case based learning: CMR in Heart Failure

Cardiac CT and MRI. Ashraf Hamdan, MD. Sheba Medical Center. Sheba Medical Center Tel Hashomer. Leviev Heart Center

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

When is strain assessment mandatory?

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)

Cardiac MR Cardiac CT

Cardiac Imaging Tests

Mechanisms and role of contrast echocardiography

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Pearls & Pitfalls in nuclear cardiology

Cardiac MRI: Appropriateness. Scott Mattson, DO, FACC Lutheran Medical Group Fort Wayne, IN

Topic. Updates on Definition of Myocardial Infarction

THE first objective of this thesis was to explore possible shape parameterizations

Infarct Involution and Improved Function During Healing of Acute Myocardial Infarction: The Role of Microvascular Obstruction #,y

Imaging congestive heart failure: role of coronary computed tomography angiography (CCTA)

Stress Echo in viability estimation of patients with ischemic heart disease and low LVEF. Prognostic implications.

Debate Should we use FFR? I will say NO.

Impaired Regional Myocardial Function Detection Using the Standard Inter-Segmental Integration SINE Wave Curve On Magnetic Resonance Imaging

Post Operative Troponin Leak: David Smyth Christchurch New Zealand

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

FFR in unstable angina and after MI F

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

High Risk PCI for Heart Failure

Clinical Summary. Live Cases I - IX

Insights into Viability- Function and Contractile Reserve

Subha V. Raman, MD, MSEE, FACC, FAHA

PCI vs. CABG From BARI to Syntax, Is The Game Over?

I have no financial disclosures

Fundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC

DELAYED ENHANCEMENT IMAGING IN CHILDREN

Viability Testing Using Dynamic Echocardiography

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

DOWNLOAD PDF MYOCARDIAL CONTRAST TWO DIMENSIONAL ECHOCARDIOGRAPHY (DEVELOPMENTS IN CARDIOVASCULAR MEDICINE)

Χ.Τρίκκα Καρδιολογική Κλινική Νοζοκομείο Ερρίκος Νησνάν

Pexelizumab and Infarct Size in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

Raja Muthupillai, PhD. Department of Diagnostic and Interventional Radiology St. Luke s Episcopal Hospital. Research Support: Philips Healthcare

Appropriateness of Stress Echocardiography and Nuclear Stress Thallium/Sesta Mibi Testing Methods

Evaluation of myocardial ischaemia

Abnormal Motion of the Interventricular Septum after Coronary Artery Bypass Graft Surgery: Comprehensive Evaluation with MR Imaging

Role of CMR in heart failure and cardiomyopathy

We report here the case of a 30-year-old professional

Conflict of Interest Disclosure

CHRONIC CAD DIAGNOSIS

Transcription:

MR Assessment of Myocardial Viability

Definition of Viability Clinical Metabolism: Presence of glucose uptake Perfusion / Perfusion reserve Morphology: Wall thickness, wall thickening Contractility: Recovery after treatment / Contractile reserve Histologic Presence of living myocytes Kim et al. Herz 2000

Merits of MRI as one-stop exam Morphology Function Perfusion Viability Coronary Artery Metabolism Flow Measurement

Merits of MRI as one-stop exam Morphology: T2 WI, T1 WI Function: Cine MR, Myocardial Tagging Perfusion: MR Perfusion (rest/stress) Viability: Delayed Enhancement, Low dose DSMR etc. Coronary Artery: Coronary MR angiography Metabolism: 31 P, 1 H MR Spectroscopy etc Flow Measurement: Coronary flow reserve

Merits of MRI as one-stop exam Morphology: T2 WI, T1 WI Function: Cine MR, Myocardial Tagging Perfusion: MR Perfusion (rest/stress) Viability: Delayed Enhancement, Low dose DSMR etc. Coronary Artery: Coronary MR angiography Metabolism: 31 P, 1 H MR Spectroscopy etc Flow Measurement: Coronary flow reserve

MRI for Myocardial Viability 1. Detection of Myocyte necrosis or scar: Delayed Enhancement (DE) MRI 2. Assessment of LV function: Myocardial mass: End-diastolic wall thickness LV contractility: End-systolic wall thickening Contractile (inotropic) reserve

ECG I. Delayed Enhancement MRI R R R Trigger Non-selective 180 o inversion trigger delay 23 α 1 α 2 α 12 α 13 α 23...... 1 2 12 TI 200-300 msecs M z Infarct Non-selective 180 o inversion M z Normal... Segmented IR Turbo-FLASH

DE-MRI vs TTC 3 days after infarct Kim et al. Circulation 1999

Reperfused vs Non-reperfused Infarction Kim et al. Circulation 1999

Delayed Enhancement MRI Area of delayed enhancement = nonviable myocardium (Bright is dead!!!) Kim RJ et al, Circulation 1999 Fieno et al, JACC 2000

Delayed Enhancement MRI CLINICAL IMPLICATIONS Detection of Myocardial Infarction - Acute Infarction - Chronic (healed) Infarction Prediction of Functional Recovery after Revascularization Treatment

DE-MRI vs SPECT Transmural infarction

DE-MRI vs SPECT DE-MRI Stress SPECT Rest SPECT Subendocardial infarction

Detection of MI: DE-MRI vs SPECT A study in 12 dogs SPECT CE-MRI TTC SPECT CE-MRI TTC Wagner et al. Lancet 2003

Detection of MI: DE-MRI vs SPECT Detection of subendocardial infarcts CE-MRI SPECT *Animal Research 100/109 (92%) 31/109 (28%) + Human Study 181/181 (100%) 96/181 (53%) *Gold standard : TTC, + Gold standard : CE-MRI Wagner et al. Lancet 2003

DE-MRI vs PET In severe ischemic heart failure, hyperenhancement on DE-MRI as a marker of myocardial scar closely agrees with PET data. Klein et al Circulation 2002

Detection of MI: DE-MRI vs PET A study in 31 patients with ischemic heart failure PET(t) PET(nt) PET(v) MRI(t) 126 11 38 MRI(nt) 7 27 51 MRI(v) 13 21 695 t : transmural, nt : non-transmural, v : viable Klein et al Circulation 2002

Lee SD 76/F C.C : Aggravated dyspnea for 1 week PMH: Diabetes mellitus for 10 years Cardiac Echo: Hypokinesia on anterolateral wall, apical to basal Cardiac enzyme : CK(EM)(50-250 U/L) : 265 CK-MB(0.0-5.0 ng/ml) : 3682 Troponin -I (0-1.5) : 20.2 EKG : Lateral AMI

Detection of Multiple Foci of MI: In Addition to the Expected Lesion

47/F chest pain Induced ischemia: mid-anterolateral wall Normal motion / no enhancement: viable!! REST STRESS

DE-MRI: CLINICAL IMPLICATIONS Detection of Myocardial Infarction - Acute Infarction - Chronic (healed) Infarction Prediction of Functional Recovery after Revascularization Treatment

DE-MRI Detection of Healed MI Large Infarct Hx: 10 months 5 months 4 months CK: 3300 IU/L 5912 IU/L 3352 IU/L MB: 294 g/l 792 g/l 389 g/l Wu et al. Lancet 2001

DE-MRI Detection of Healed MI Small Infarct Hx: 13 months 2 months 3 months CK: 513 IU/L 219 IU/L 508 IU/L MB: 62 g/l 12 g/l 35 g/l Wu et al. Lancet 2001

Limitations of DE-MRI: Differentiation between Acute and Chronic MI? T2 WI SPECT Lim TH et al, JMRI 1997

DE-MRI vs T2 MRI T2 WI Acute MI ( 5 days ago) DE-MRI

DE-MRI vs T2 MRI T2 WI Chronic MI (9 years Hx) DE-MRI

DE-MRI: CLINICAL IMPLICATIONS Detection of Myocardial Infarction - Acute Infarction - Chronic (healed) Infarction Prediction of Functional Recovery after Revascularization Treatment

DE-MRI: Functional Recovery DE-MRI Pre-tx cine Post-tx cine 3 VD, F/U 3 months after CABG EF: 47.4% 63.4%

DE-MRI: Functional Recovery DE-MRI Pre-tx cine Post-tx cine 3 VD, F/U 3 months after CABG EF: 17.8% 19.4%

Assessment of Myocardial Salvage An animal study in 15 dogs 45 min Occlusion 90 min Occlusion Permanent Occlusion Hillenbrand et al. Circulation 2000

Assessment of Myocardial Salvage An animal study in 15 dogs Mean Trnasmural Extent of Hyperenhancement % Segment with Improved Wall Motion 34 % 12 % 34 % 12 % Mean Transmural Extent of Hyperenhancement on Day 3 in Each Group 0 1 ~ 25 26 ~ 50 51 ~ 75 76 ~100 % Hyperenhancement on Day 3 Hillenbrand et al. Circulation 2000

Assessment of Myocardial Salvage A prospective study in 61 patients 10 % 1.7 % LAD LCX RCA Kim et al. N Engl J Med 2000

MRI for Myocardial Viability 1. Detection of Myocyte necrosis or scar: DE-MRI 2. Assessment of LV function: Myocardial mass: End-diastolic wall thickness LV contractility: End-systolic wall thickening Contractile (inotropic) reserve

2. LV Function: Cine MRI

Analysis of LV Function Visual qualitative assessment Quantitative assessment Thickness (ED) Thickening Motion

Quantitative Assessment More accurate than visual assessment 47/M Acute myocardial infarction Echo: normal wall motion

Real Time Cine MR Retrospective TFE Synchronized Real Time Multi Slice (M2D) B-TFE Free breathing, real time, no breathhold Pediatric patients, sick patients Breathhold retrospective btfe Free breathing real time cine

2. LV Function: Low Dose DSMR contractile (inotropic) reserve DE-MRI: impaired specificity as a predictor of functional recovery in non-transmural scars (1% to 74%). Low dose DSMR: superior to DE-MRI as a predictor of functional recovery and does not depend on the transmurality of scar. DE-MRI and DSMR provide complementary information. Wellnhofer et al, Circulation 2004

DSE vs DSMR Rest 10µg 20µg DSE DSMR

Low Dose DSMR Rest MRI Low dose DSMR

Low Dose DSMR Pre CABG Post CABG

Low Dose DSMR Viability Rest 10µg 20µg

2. LV Function: Tagged MRI Wall Motion Abnormality due to ICMP

Tagged MRI Radial thickening Circumferential shortening

Conclusion 1. Delayed enhancement MRI Detection of area with myocyte necrosis Acute MI vs. chronic MI (with T2 MRI) Prediction of functional recovery 2. Cine MRI / Tagged cine MRI / DSMR Myocardial mass Contractile function inotropic reserve

Thank You!! Tae-Hwan Lim, MD, PhD Department of Radiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea